Net Promoter Score (NPS)HealthTechSeries B

Net Promoter Score (NPS) for HealthTech at Series B

2026 data · Sample size: 272 · Source: HubSpot Marketing Statistics 2025

25th %ile

27.3

Median

47.3

75th %ile

62.6

90th %ile

92.6

▬Trending stable year-over-year

About This Metric

Customer loyalty metric measuring willingness to recommend your product on a -100 to +100 scale.

% Promoters (9-10) - % Detractors (0-6)

Higher is better · Unit: score

How to Improve

Implement a voice‑of‑customer program that systematically collects and acts on feedback. Invest in product quality and reliability as the foundation of customer satisfaction. Build self‑service resources that empower customers to solve problems independently. Create customer advisory boards that make top customers feel heard and valued. Launch surprise‑and‑delight programs to turn satisfied customers into promoters.

Ehsan's Analysis

HealthTech NPS has a peculiar split: clinicians who use the product daily rate it 30-50 points lower than administrators who purchased it. Epic's NPS among hospital CIOs is 60+; among physicians who use it, it is negative. This gap exists because healthcare purchasing decisions are made by people who do not use the product. The implication for healthtech startups: measure TWO NPS scores — buyer NPS (predicts renewal) and user NPS (predicts daily adoption and workflow compliance). If user NPS is below 0, your product will be underutilized regardless of contract value, leading to eventual non-renewal. The healthtech companies with aligned NPS (both buyer and user above 30) — Doximity among physicians, Athenahealth among small practices — have structurally lower churn. The product fix is usually not features but workflow redesign: clinicians hate products that add steps to their day and love products that eliminate steps.

Ehsan Jahandarpour

AI Growth Strategist & Fractional CMO

Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council

Frequently Asked Questions

What is a good Net Promoter Score (NPS) for HealthTech companies at Series B stage?

The median Net Promoter Score (NPS) for HealthTech companies at the Series B stage is 47.3 points. Top‑quartile companies (75th percentile) significantly outperform this baseline. The most important factor is consistent improvement over time rather than hitting any single target number.

How does Net Promoter Score (NPS) differ by company stage in HealthTech?

Net Promoter Score (NPS) typically improves as HealthTech companies mature from seed through growth stage. Earlier‑stage companies should benchmark against stage‑appropriate peers rather than comparing themselves to mature companies.

How often should HealthTech companies measure Net Promoter Score (NPS)?

HealthTech companies at the Series B stage should track Net Promoter Score (NPS) quarterly through systematic surveys and continuous monitoring. Set up automated dashboards and alerts for significant deviations from your baseline.

What factors most impact Net Promoter Score (NPS) in the HealthTech sector?

In HealthTech, the primary factors impacting Net Promoter Score (NPS) include product‑market fit maturity, competitive landscape intensity, customer segmentation strategy, pricing optimization, and operational efficiency. Series B‑stage companies should focus on the one or two highest‑leverage factors rather than trying to optimize everything simultaneously.

How does Net Promoter Score (NPS) for HealthTech compare to cross‑industry benchmarks?

HealthTech Net Promoter Score (NPS) benchmarks can differ significantly from cross‑industry averages due to factors specific to the HealthTech vertical including customer acquisition dynamics, competitive intensity, and typical deal sizes. Always compare against industry‑specific benchmarks rather than broad averages for meaningful insights.